Review

Pharm D Program: Is it Necessary in BRICS?

Pei Yu1★, Beverley Joy Wilson2, Amy Claire Bobbins2, Sunitha Chandrasekhar Srinivas2, Gang Yin1★ Corresponding author

  1. 1College of Pharmacy, Jinan University, Guangzhou, CHINA.
  2. 2Faculty of Pharmacy, Rhodes University, Grahamstown, SOUTH AFRICA.

CORRESPONDENCE

Pei Yu

College of Pharmacy, Jinan University, Guangzhou, CHINA.

pennypeiyu@163.com

Received: 30-09-2019; Revised: 02-12-2019; Accepted: 26-02-2020.

Volume 54, Issue 3 · pp. 517–525 · PUBLISHED 2020 · DOI: 10.5530/ijper.54.3.100

View on IJPER original site ↗

ABSTRACT

The various trajectories of the development of the Doctor of Pharmacy (Pharm D) programs in BRICS countries were reviewed individually, showing the progress of Pharm D programs in each context. Evidence from developed countries indicates that Pharm D programs have contributed towards the positive development of public health and a country’s local health requirements, with well-trained clinical pharmacists having a key role in the health and economic development of these emerging powers. The health systems of BRICS countries are heavily challenged with a dual burden of disease, weak health infrastructure and public health initiatives. Thus, not only will the development of Pharm D programs in BRICS countries strengthen pharmacy education contributing to a pharmacy workforce more readily able to target health-related problems, demographic and epidemiological shifts; but will also better equip public health systems with more patient-centered pharmaceutical care necessary for evidence-based, individualized and cost-effective healthcare.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Yu, P., Wilson, B. J., Bobbins, A. C., Srinivas, S. C., & Yin, G. (2020). Pharm D Program: Is it Necessary in BRICS?. Indian Journal of Pharmaceutical Education and Research, 54(3), 517–525. https://doi.org/10.5530/ijper.54.3.100